Escherichia coli
Escherichia coli is a Gram-negative, rod-shaped bacterium of the family Enterobacteriaceae and a normal inhabitant of the lower intestinal tract of humans and other warm-blooded animals.
Escherichia coli is a Gram-negative, rod-shaped bacterium of the family Enterobacteriaceae and a normal inhabitant of the lower intestinal tract of humans and other warm-blooded animals. It is a facultative anaerobe that grows rapidly on simple defined media, and its small, fully sequenced genome and extensive genetic toolkit have made it the reference prokaryotic model organism for molecular biology. Most strains are harmless commensals, while defined lineages — including enterohemorrhagic E. coli O157:H7 and extraintestinal pathogenic strains — cause diarrheal illness, urinary tract infection, neonatal meningitis, and sepsis. Foodborne and wound-associated E. coli is a routine benchmark Gram-negative organism in antimicrobial testing, typically evaluated alongside Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans to distinguish activity across the Gram-negative outer membrane, the Gram-positive cell wall, and the fungal envelope.
The outer membrane of E. coli, with its lipopolysaccharide leaflet and selective porins, restricts entry of hydrophobic and large-molecule antimicrobials and underlies much of the organism's intrinsic resistance; acquired β-lactamases, including carbapenemases such as NDM-5, extend that resistance to front-line drugs. E. coli also forms biofilms in which an extracellular polymeric matrix reduces antibiotic penetration and metabolic activity, a phenotype targeted by plant-derived agents such as carvacrol and other essential-oil constituents, by polyphenols including rutin, kaempferol, curcumin, and resveratrol, and by metal and metal-oxide nanoparticles such as silver, zinc oxide, and selenium nanoparticles. Many of these agents act at least in part by generating reactive oxygen species and hydrogen peroxide that impose oxidative stress and compromise membrane integrity, effects often measured together with antioxidant and glutathione-related readouts. In parallel, E. coli remains a principal engineering chassis: serine-integrase and CRISPR-Cas systems, including CRISPR-Cas12a, permit precise, iterative genome modification, supporting recombinant protein expression in strains such as BL21(DE3) and metabolic-engineering routes to amino acid, nucleotides, glycosides, and related compounds, as well as its use in biosensor and synthetic-biology platforms.
Where the papers sit
25 papers from the last 6 months study escherichia coli directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 2 human data · 21 preclinical · 2 unclassified
Themes 4 themes · 1 paradigm shift
-
Antimicrobial Food Technologies
Plant extracts, essential oils, organic acids, and microbial lipids are being developed as antibacterial food and oral-health interventions. Encapsulation in cyclodextrins, hydrogels, novasomes, films, and starch masks aims to stabilize actives and control release. GC-MS, docking, MIC and biofilm assays, and phytochemical profiling provide activity readouts, while CRISPR/Cas12a and MALDI workflows accelerate pathogen or fermentation monitoring. Evidence remains largely in vitro and formulation-focused, with limited validation of clinical efficacy or manufacturing robustness.
11 papers · 44%
-
Infected Wound Nanotherapies
Infected wound treatment is moving toward multifunctional materials that combine antibacterial action with antioxidant activity, tissue repair, and controlled drug release. Hydrogels, silver or MgO nanoparticles, solid lipid nanoparticles, and programmable microneedles target Staphylococcus aureus and Pseudomonas aeruginosa. Photothermal activation and phytochemical or antibiotic delivery recur as ways to improve local pathogen clearance. Healing, neovascularization, and diabetic wound outcomes are increasingly assessed alongside antimicrobial activity, but evidence remains mainly preclinical.
6 papers · 24%
-
Bacterial Growth and Control
Bacterial growth is considered in three different contexts. Photosynthetic consortia couple acetate production to heterotrophic 1-butanol synthesis, while plant products inhibit pathogens or support probiotic growth. Essential oils add biofilm viability, biomass, metabolic activity, and membrane integrity as control endpoints. The shared focus is bacterial growth, metabolism, and inhibition rather than a unified translational program.
3 papers · 12%
-
Others — E. coli Biology and Applications
Drug-resistant NDM-5 E. coli, genome integration, host signaling, chronic pancreatitis fibrosis, and plant antibacterial activity appear together. The set has no single biological question or shared therapeutic direction. Its recurring link is the use of E. coli in clinical surveillance, genetic engineering, host-interaction studies, or antimicrobial testing. Resistance mechanisms and HtpG or TLR5 effects therefore remain distinct lines of work rather than parts of one advancing program.
5 papers · 20%
Escherichia coli is used as an engineered biotechnology chassis, not only as a pathogen to suppress
The photosynthetic-acetate consortium study, which engineers E. coli for heterotrophic 1-butanol production, and the SARGE study, which develops E. coli as a host for rapid, iterative genome integration, replace the pathogen-centered assumption dominant in the set with two independent uses of the organism as a programmable production and engineering platform. Their results shift the practical role of E. coli from an antibacterial test target to an instrument for manufacturing chemicals and constructing complex genomes 42726284Sep 42319839Jun.
Papers
The 25 papers from the last 6 months that study escherichia coli directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Antimicrobial Food Technologies (11)
- Antibacterial Activities of Selected Plant Extracts on Cariogenic Microbes. Oral health & preventive dentistry · 11 Nov 2026 PMID 43012461
- Validation of a MALDI Intact Cell Mass Spectrometry Workflow for Routine Application in Monitoring Industrial E. coli Fermentations. Journal of mass spectrometry : JMS · 14 Oct 2026 PMID 42873138
- In Silico and In Vitro Evaluation of Atriplex halimus: Antibacterial Activity, Molecular Docking, ADMET Profiling, and Cytotoxicity Assessment. Chemistry & biodiversity · 31 Aug 2026 PMID 42673104
- Combined experimental and molecular docking investigation of a cyclodextrin-myrrh oil inclusion complex: implications for solubility and antibacterial activity. International journal of pharmaceutics · 16 Jul 2026 PMID 42462917
- Simultaneous detection of multiple foodborne pathogens using a CRISPR/Cas12a-based pump-free microfluidic chip. Analytical and bioanalytical chemistry · 10 Jul 2026 PMID 42432276
- Hyaluronate-coated novasomes as a nanoplatform for targeted delivery of Beta vulgaris subsp. cicla extract: formulation, characterization, and phytochemical profiling. Scientific reports · 16 Jun 2026 PMID 42303711
- Co-encapsulation of formic acid and Satureja hortensis essential oil enhances antibacterial and anti-inflammatory activities against Salmonella enterica. Journal of microbiological methods · 16 Jun 2026 PMID 42302970
- Multifunctional chitosan films enriched with artichoke stem extract and microbial lipids for active food packaging. International journal of biological macromolecules · 3 Jun 2026 PMID 42235764
- A high-amylose maize starch hydrogel mask for stabilized encapsulation of thyme essential oil with Higuchi-controlled release. International journal of biological macromolecules · 31 May 2026 PMID 42219099
- A two-stage signal enhancement method integrating the Gaussian mixture model and adaptive rolling ball technique for ultrasensitive fluorescent immunochromatographic detection. Analytical methods : advancing methods and applications · 27 May 2026 PMID 42200343
- Phytochemical signatures and multifunctional bioactivities of two Ocimum basilicum varieties (Obb vs. Obg): antimicrobial, antioxidant, and anticancer potential. Scientific reports · 25 May 2026 PMID 42185519
Infected Wound Nanotherapies (6)
- Formulation development and optimization of sparfloxacin-loaded solid lipid nanoparticles integrated with microneedles for the treatment of biofilm-infected wounds. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 12 Jul 2026 PMID 42437591
- Resveratrol-Engineered Modified Chitosan-PVP-AgNP Composite Hydrogel Patch: A Potential Antibacterial and Antioxidant Biomaterial for Infected Wound Healing. ACS applied bio materials · 3 Jul 2026 PMID 42397260
- Biosynthesis of ecofriendly antibacterial nanoparticles with healing effects in a murine diabetic skin infection model. Scientific reports · 15 Jun 2026 PMID 42297939
- Synthesis of phytochemical-enriched MgO nanoparticles using Sonneratia ovata leaf extract for photocatalytic activity and inactivation of bacteria. Journal of environmental management · 14 Jun 2026 PMID 42289157
- Photothermal-Responsive Multifunctional Hydrogels as Integrated Smart Carriers for Antibiotic Controlled Release and Infected Wound Therapy. Langmuir : the ACS journal of surfaces and colloids · 8 Jun 2026 PMID 42257624
- Programmable core-shell microneedles with marine chondroitin sulfate core and chito-oligosaccharide shell disrupt the pathological microenvironment cycle for enhanced healing of infected burn wounds. International journal of biological macromolecules · 3 Jun 2026 PMID 42235776
Bacterial Growth and Control (3)
- Synthetic consortia towards photosynthetically derived acetate for heterotrophic production of 1-butanol. Applied microbiology and biotechnology · 11 Sept 2026 PMID 42726284
- Goldenberry (Physalis peruviana L.) juice inhibits foodborne pathogens while promoting probiotic bacterial growth. Scientific reports · 16 Jul 2026 PMID 42463768
- Chemical fingerprints of Lamiaceae essential oils: targeting biofilm viability, biomass, metabolic activity, and membrane integrity. Biofouling · 23 Jun 2026 PMID 42332877
Others — E. coli Biology and Applications (5)
- HtpG-High-Expressing Escherichia coli Promotes Fibrosis in Chronic Pancreatitis. Gastroenterology · 13 Oct 2026 PMID 42869256
- Outbreak of aztreonam-avibactam-resistant NDM-5-producing Escherichia coli isolates in a hospital of Paris. Microbiology spectrum · 13 Aug 2026 PMID 42593110
- Antibacterial Activities of Guava (Psidium guajava) Leaf Aqueous Extract Against Staphylococcus aureus and Escherichia coli. Mymensingh medical journal : MMJ · 30 Jun 2026 PMID 42375034
- SARGE: Serine Integrase-Assisted Rapid Genome Integration through Cassette Exchange in Escherichia coli. ACS synthetic biology · 19 Jun 2026 PMID 42319839
- Altered flagellin-TLR5 signaling pathway in the interaction between the host and laboratory Escherichia coli strains engineered for enhanced intestinal colonization in mice. Bioscience, biotechnology, and biochemistry · 9 Jun 2026 PMID 42264462
By study type
Human data, design not indexed (2)
- Antibacterial Activities of Selected Plant Extracts on Cariogenic Microbes. Oral health & preventive dentistry · 11 Nov 2026 PMID 43012461
- Outbreak of aztreonam-avibactam-resistant NDM-5-producing Escherichia coli isolates in a hospital of Paris. Microbiology spectrum · 13 Aug 2026 PMID 42593110
Preclinical: animal, cell and lab studies (21)
- Validation of a MALDI Intact Cell Mass Spectrometry Workflow for Routine Application in Monitoring Industrial E. coli Fermentations. Journal of mass spectrometry : JMS · 14 Oct 2026 PMID 42873138
- Synthetic consortia towards photosynthetically derived acetate for heterotrophic production of 1-butanol. Applied microbiology and biotechnology · 11 Sept 2026 PMID 42726284
- In Silico and In Vitro Evaluation of Atriplex halimus: Antibacterial Activity, Molecular Docking, ADMET Profiling, and Cytotoxicity Assessment. Chemistry & biodiversity · 31 Aug 2026 PMID 42673104
- Goldenberry (Physalis peruviana L.) juice inhibits foodborne pathogens while promoting probiotic bacterial growth. Scientific reports · 16 Jul 2026 PMID 42463768
- Combined experimental and molecular docking investigation of a cyclodextrin-myrrh oil inclusion complex: implications for solubility and antibacterial activity. International journal of pharmaceutics · 16 Jul 2026 PMID 42462917
- Simultaneous detection of multiple foodborne pathogens using a CRISPR/Cas12a-based pump-free microfluidic chip. Analytical and bioanalytical chemistry · 10 Jul 2026 PMID 42432276
- Resveratrol-Engineered Modified Chitosan-PVP-AgNP Composite Hydrogel Patch: A Potential Antibacterial and Antioxidant Biomaterial for Infected Wound Healing. ACS applied bio materials · 3 Jul 2026 PMID 42397260
- Antibacterial Activities of Guava (Psidium guajava) Leaf Aqueous Extract Against Staphylococcus aureus and Escherichia coli. Mymensingh medical journal : MMJ · 30 Jun 2026 PMID 42375034
- Chemical fingerprints of Lamiaceae essential oils: targeting biofilm viability, biomass, metabolic activity, and membrane integrity. Biofouling · 23 Jun 2026 PMID 42332877
- SARGE: Serine Integrase-Assisted Rapid Genome Integration through Cassette Exchange in Escherichia coli. ACS synthetic biology · 19 Jun 2026 PMID 42319839
- Hyaluronate-coated novasomes as a nanoplatform for targeted delivery of Beta vulgaris subsp. cicla extract: formulation, characterization, and phytochemical profiling. Scientific reports · 16 Jun 2026 PMID 42303711
- Co-encapsulation of formic acid and Satureja hortensis essential oil enhances antibacterial and anti-inflammatory activities against Salmonella enterica. Journal of microbiological methods · 16 Jun 2026 PMID 42302970
- Biosynthesis of ecofriendly antibacterial nanoparticles with healing effects in a murine diabetic skin infection model. Scientific reports · 15 Jun 2026 PMID 42297939
- Synthesis of phytochemical-enriched MgO nanoparticles using Sonneratia ovata leaf extract for photocatalytic activity and inactivation of bacteria. Journal of environmental management · 14 Jun 2026 PMID 42289157
- Altered flagellin-TLR5 signaling pathway in the interaction between the host and laboratory Escherichia coli strains engineered for enhanced intestinal colonization in mice. Bioscience, biotechnology, and biochemistry · 9 Jun 2026 PMID 42264462
- Photothermal-Responsive Multifunctional Hydrogels as Integrated Smart Carriers for Antibiotic Controlled Release and Infected Wound Therapy. Langmuir : the ACS journal of surfaces and colloids · 8 Jun 2026 PMID 42257624
- Programmable core-shell microneedles with marine chondroitin sulfate core and chito-oligosaccharide shell disrupt the pathological microenvironment cycle for enhanced healing of infected burn wounds. International journal of biological macromolecules · 3 Jun 2026 PMID 42235776
- Multifunctional chitosan films enriched with artichoke stem extract and microbial lipids for active food packaging. International journal of biological macromolecules · 3 Jun 2026 PMID 42235764
- A high-amylose maize starch hydrogel mask for stabilized encapsulation of thyme essential oil with Higuchi-controlled release. International journal of biological macromolecules · 31 May 2026 PMID 42219099
- A two-stage signal enhancement method integrating the Gaussian mixture model and adaptive rolling ball technique for ultrasensitive fluorescent immunochromatographic detection. Analytical methods : advancing methods and applications · 27 May 2026 PMID 42200343
- Phytochemical signatures and multifunctional bioactivities of two Ocimum basilicum varieties (Obb vs. Obg): antimicrobial, antioxidant, and anticancer potential. Scientific reports · 25 May 2026 PMID 42185519
Unclassified: not yet indexed with MeSH (2)
- HtpG-High-Expressing Escherichia coli Promotes Fibrosis in Chronic Pancreatitis. Gastroenterology · 13 Oct 2026 PMID 42869256
- Formulation development and optimization of sparfloxacin-loaded solid lipid nanoparticles integrated with microneedles for the treatment of biofilm-infected wounds. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 12 Jul 2026 PMID 42437591
Written from 25 PubMed abstracts, each one listed by PMID above. Published: 2026-07-01. Last written: 2026-09-13 by GPT. Reviewed by a human editor on 2026-07-23. Drafted by language models from published abstracts; not medical advice.